{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:33:38Z","timestamp":1787564018734,"version":"build-2736575974"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Anti\u2013leucine-rich glioma-inactivated 1 (LGI1) antibody\u2013associated autoimmune encephalitis is a treatable disorder characterized by subacute cognitive impairment. Efgartigimod is a neonatal Fc receptor (FcRn) antagonist that reduces circulating IgG levels. It is approved for the treatment of generalized myasthenia gravis (MG) and has recently been explored as a therapeutic option for antibody-mediated neurological diseases. We report a patient who developed anti-LGI1 antibody\u2013associated encephalitis during ongoing efgartigimod therapy despite reduced serum IgG levels, raising considerations regarding the mechanisms of central nervous system autoimmunity under FcRn inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 72-year-old woman with thymoma-associated MG receiving efgartigimod was evaluated after presenting with rapidly progressive memory impairment. Clinical assessment included neurological examination, brain magnetic resonance imaging, cerebrospinal fluid analysis, and serological testing for neuronal and paraneoplastic antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Brain magnetic resonance imaging revealed bilateral medial temporal lobe hyperintensities. Cerebrospinal fluid analysis showed negative LGI1 antibodies and a normal IgG index (0.524), with no evidence suggestive of intrathecal IgG synthesis. Subsequent serological testing confirmed anti-LGI1 antibody positivity, and anti-titin antibodies were also detected. High-dose intravenous methylprednisolone therapy resulted in marked clinical improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case highlights a clinically relevant scenario in which autoimmune encephalitis can arise during FcRn inhibition therapy, suggesting that reduction of circulating IgG alone may be insufficient to prevent central nervous system autoimmunity. The absence of intrathecal IgG synthesis raises the possibility that pathogenic antibodies were predominantly derived from the peripheral compartment. These findings underscore the pharmacodynamic limitations of FcRn inhibition, particularly in the setting of thymoma-associated immune dysregulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1854357","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:31:03Z","timestamp":1779093063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Anti-LGI1 encephalitis during FcRn inhibition with efgartigimod for myasthenia gravis: implications for the limitations of IgG recycling blockade"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuka","family":"Komatsu","sequence":"first","affiliation":[{"name":"Department of Neurology, Nara Medical University","place":["Nara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Eura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nara Medical University","place":["Nara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Nishimori","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nara Medical University","place":["Nara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kakehi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nara Medical University","place":["Nara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kiriyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nara Medical University","place":["Nara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Sugie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nara Medical University","place":["Nara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1756285617722347","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1444288","article-title":"Case report: Rapid symptom relief in autoimmune encephalitis with efgartigimod: a three-patient case series","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 <scp>LGI<\/scp> 1\/ <scp>CASPR<\/scp> 2\u2010 <scp>I<\/scp> g <scp>G<\/scp> \u2013positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa104","article-title":"Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms","volume":"143","author":"Ramberger","year":"2020","journal-title":"Brain"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy253","article-title":"LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit-Pedrol","year":"2018","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: The influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e200455","DOI":"10.1212\/NXI.0000000000200455","article-title":"Unknown immunoregulatory effects of FcRn inhibition by efgartigimod in myasthenia gravis: A new mechanism of action beyond IgG reduction","volume":"12","author":"Tarasco","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1069368","article-title":"The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined","volume":"13","author":"Mu\u00f1oz-S\u00e1nchez","year":"2022","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00840.x","article-title":"Expression of the neonatal Fc receptor (FcRn) at the blood\u2013brain barrier","volume":"81","author":"Schlachetzki","year":"2002","journal-title":"J Neurochem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719432","article-title":"CSF-neurofilament light chain levels in NMDAR and LGI1 encephalitis: A national cohort study","volume":"12","author":"Nissen","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1854357\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:31:06Z","timestamp":1779093066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1854357\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":16,"alternative-id":["10.3389\/fimmu.2026.1854357"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1854357","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"1854357"}}